Skip to content
10-Q

Quarterly Report

BIOSCIENCE HEALTH INNOVATIONS INC. BHIC

0001185185-24-000738

← back to feed
Filed
Jul 30, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Jul 30, 2024 42.1M sh
Cash And Equivalents Q2 2024 · Jun 30, 2024 $143.92K
Cash And Equivalents Q2 2024 · Dec 31, 2023 $19.24K
Total Liabilities Q2 2024 · Jun 30, 2024 $24.51K
Total Liabilities Q2 2024 · Dec 31, 2023 $100.15K
Current Assets Q2 2024 · Jun 30, 2024 $213.59K
Current Assets Q2 2024 · Dec 31, 2023 $93.39K
Total Assets Q2 2024 · Jun 30, 2024 $213.59K
Total Assets Q2 2024 · Dec 31, 2023 $93.39K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$181.01K
Stockholders Equity Q2 2024 · Jun 30, 2023 −$54.25K
Stockholders Equity Q2 2024 · Mar 31, 2023 −$88.99K
Stockholders Equity Q2 2024 · Dec 31, 2022 −$17.18K
Sga Expense Q2 2024 · Jun 30, 2023 $138.73K
Sga Expense Q2 2024 · Jun 30, 2023 $231.04K
Net Income Q2 2024 · Jun 30, 2023 −$85.26K
Net Income Q2 2024 · Jun 30, 2023 −$155.98K
Net Income Q2 2024 · Mar 31, 2023 −$70.72K
Operating Income Q2 2024 · Jun 30, 2023 −$85.26K
Operating Income Q2 2024 · Jun 30, 2023 −$155.98K
Gross Profit Q2 2024 · Jun 30, 2023 $59.97K
Gross Profit Q2 2024 · Jun 30, 2023 $87.56K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $9.5K
Cost Of Revenue Q2 2024 · Jun 30, 2023 $14.25K
Revenue Q2 2024 · Jun 30, 2023 $69.47K
Revenue Q2 2024 · Jun 30, 2023 $101.8K